Keyword Search
Legend:
CC = Vancouver Convention Centre F = Fairmont Waterfront Vancouver
* = applied session ! = JSM meeting theme
|
Keyword Search Criteria: patient-reported outcome returned 6 record(s)
|
|
Tuesday, 07/31/2018
|
Completion Rates and Considerations for Analyses of Patient-Reported Outcomes in Open-Label Cancer Trials: FDA Review of Trials, 2007 - 2017
Jessica K. Roydhouse, Office of Hematology and Oncology Products, US Food and Drug Administration; Mallorie H. Fiero, Office of Biostatistics, US Food and Drug Administration; Bellinda King-Kallimanis, Office of Hematology and Oncology Products, US Food and Drug Administration; Paul G. Kluetz, Oncology Center of Excellence, US Food and Drug Administration
|
|
Wednesday, 08/01/2018
|
Analysis of Multiple Thresholds in a Responder Analysis of Patient-Reported Outcome Measures
Lysbeth Floden, Clinical Outcome Solutions; Melanie L Bell, University of Arizona; Stacie Hudgens, Clinical Outcome Solutions
|
Single Item Analysis of Patient-Reported Outcome Measures in a Phase III Randomized Controlled Trial
Stacie Hudgens, Clinical Outcome Solutions; Lysbeth Floden, Clinical Outcome Solutions
|
Single Item Analysis of Patient-Reported Outcome Measures in a Phase III Randomized Controlled Trial
Stacie Hudgens, Clinical Outcome Solutions; Lysbeth Floden, Clinical Outcome Solutions
9:00 AM
|
Analysis of Multiple Thresholds in a Responder Analysis of Patient-Reported Outcome Measures
Lysbeth Floden, Clinical Outcome Solutions; Melanie L Bell, University of Arizona; Stacie Hudgens, Clinical Outcome Solutions
9:45 AM
|
Opportunities of Using Real World Data to Inform Regulatory Considerations for Medical Devices
Martin Ho, FDA
2:25 PM
|
|
|
